These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 2621422

  • 1. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
    Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S.
    J Lipid Res; 1989 Dec; 30(12):1953-62. PubMed ID: 2621422
    [Abstract] [Full Text] [Related]

  • 2. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, Eskreis D, Katz S.
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [Abstract] [Full Text] [Related]

  • 3. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
    Stiehl A, Rudolph G, Raedsch R, Möller B, Hopf U, Lotterer E, Bircher J, Fölsch U, Klaus J, Endele R.
    Hepatology; 1990 Sep; 12(3 Pt 1):492-7. PubMed ID: 2401455
    [Abstract] [Full Text] [Related]

  • 4. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.
    Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Kruizinga W.
    Biochim Biophys Acta; 1987 Feb 14; 917(2):238-46. PubMed ID: 3801500
    [Abstract] [Full Text] [Related]

  • 5. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Batta AK, Salen G, Abroon J.
    Am J Gastroenterol; 1997 Jun 14; 92(6):1035-7. PubMed ID: 9177526
    [Abstract] [Full Text] [Related]

  • 6. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
    Mazzella G, Parini P, Bazzoli F, Villanova N, Festi D, Aldini R, Roda A, Cipolla A, Polimeni C, Tonelli D.
    Dig Dis Sci; 1993 May 14; 38(5):896-902. PubMed ID: 8482188
    [Abstract] [Full Text] [Related]

  • 7. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
    Güldütuna S, Leuschner M, Wunderlich N, Nickel A, Bhatti S, Hübner K, Leuschner U.
    Eur J Clin Pharmacol; 1993 May 14; 45(3):221-5. PubMed ID: 8276045
    [Abstract] [Full Text] [Related]

  • 8. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.
    Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G.
    Hepatology; 1992 Apr 14; 15(4):603-8. PubMed ID: 1551637
    [Abstract] [Full Text] [Related]

  • 9. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B, Carithers RL, Maddrey WC, Munoz S, Garcia-Tsao G, Bonner GF, Boyer JL, Luketic VA, Shiffman ML, Peters MG, White H, Zetterman RK, Risser R, Rossi SS, Hofmann AF.
    Hepatology; 1999 Jun 14; 29(6):1649-54. PubMed ID: 10347103
    [Abstract] [Full Text] [Related]

  • 10. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
    Poupon RE, Chrétien Y, Poupon R, Paumgartner G.
    Hepatology; 1993 Apr 14; 17(4):599-604. PubMed ID: 8477964
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y, Poupon R, Gherardt MF, Chazouilleres O, Labbe D, Myara A, Trivin F.
    Gut; 1989 Aug 14; 30(8):1110-5. PubMed ID: 2767508
    [Abstract] [Full Text] [Related]

  • 15. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E, Mazzella G, Bazzoli F, Villanova N, Minutello A, Simoni P, Ronchi M, Poggi C, Festi D, Aldini R.
    Dig Dis Sci; 1989 Dec 14; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD.
    Hepatology; 1991 Jun 14; 13(6):1076-83. PubMed ID: 2050325
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M, Colombo C, Setchell KD.
    Hepatology; 1990 Aug 14; 12(2):322-34. PubMed ID: 2391071
    [Abstract] [Full Text] [Related]

  • 20. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
    Crosignani A, Battezzati PM, Setchell KD, Camisasca M, Bertolini E, Roda A, Zuin M, Podda M.
    Hepatology; 1991 Feb 14; 13(2):339-44. PubMed ID: 1671665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.